Literature DB >> 17878768

The utility of the FIM+FAM for assessing traumatic brain injury day program outcomes.

Ronald T Seel1, Greg Wright, Tracey Wallace, Sary Newman, Leanne Dennis.   

Abstract

OBJECTIVE: To evaluate the effectiveness of the FIM+FAM as a primary outcome measure for traumatic brain injury (TBI) comprehensive day programs.
DESIGN: Retrospective data analysis.
SETTING: Single center, TBI comprehensive day program facility. PARTICIPANTS: A demographically and regionally diverse sample of 105 persons with moderate or severe TBI admitted to the Shepherd Pathways comprehensive TBI day rehabilitation program. MAIN OUTCOME MEASURES: Functional Independence Measure + Functional Assessment Measure (FIM+FAM).
RESULTS: Twenty-eight percent or fewer of participants reached ceiling effects on 25 of the 30 FIM+FAM items at day program admission with only 2% of clients rated above ceiling score levels on the FIM+FAM total score. The criteria of Guyatt et al showed that 20 of the 30 FIM+FAM items showed clinically meaningful improvements in 60% or more of clients. On average, clients with TBI improved over 27 points on the FIM+FAM total score. Fifteen of 30 items showed ceiling effects of 33% or less at discharge where only 25% of clients exceeded the FIM+FAM total score ceiling threshold. Discharge FIM+FAM motor scale was a very good predictor of the need for additional single service physical therapy. However, reaching ceiling rating on the FIM+FAM cognitive scale demonstrated poor specificity (0.28) and negative predictive power (0.42) for the need for additional speech/cognitive therapy services.
CONCLUSIONS: The FIM+FAM demonstrated utility as an outcome measure for TBI comprehensive day program treatment in the current milieu. Future research is required to replicate and extend the current findings.

Entities:  

Mesh:

Year:  2007        PMID: 17878768     DOI: 10.1097/01.HTR.0000290971.56130.c8

Source DB:  PubMed          Journal:  J Head Trauma Rehabil        ISSN: 0885-9701            Impact factor:   2.710


  7 in total

1.  Vagus nerve stimulation to augment recovery from severe traumatic brain injury impeding consciousness: a prospective pilot clinical trial.

Authors:  Chen Shi; Steven R Flanagan; Uzma Samadani
Journal:  Neurol Res       Date:  2013-04       Impact factor: 2.448

2.  The Safety Assessment Measure for persons with traumatic brain injury: Item pool development and content validity.

Authors:  Ronald T Seel; Stephen Macciocchi; Craig A Velozo; Kimether Shari; Nicole Thompson; Allen W Heinemann; Angelle M Sander; David Sleet
Journal:  NeuroRehabilitation       Date:  2016-06-30       Impact factor: 2.138

3.  Atypical Within-Session Motor Procedural Learning after Traumatic Brain Injury but Well-Preserved Between-Session Procedural Memory Consolidation.

Authors:  Maria Korman; Sharon Shaklai; Keren Cisamariu; Carmit Gal; Rinatia Maaravi-Hesseg; Ishay Levy; Ofer Keren; Avi Karni; Yaron Sacher
Journal:  Front Hum Neurosci       Date:  2018-01-30       Impact factor: 3.169

4.  Skill-learning by observation-training with patients after traumatic brain injury.

Authors:  Einat Avraham; Yaron Sacher; Rinatia Maaravi-Hesseg; Avi Karni; Ravid Doron
Journal:  Front Hum Neurosci       Date:  2022-08-31       Impact factor: 3.473

5.  Regional Variations in Rehabilitation Outcomes of Adult Patients With Traumatic Brain Injury: A Uniform Data System for Medical Rehabilitation Investigation.

Authors:  Tolu O Oyesanya; Tim P Moran; Tamara R Espinoza; David W Wright
Journal:  Arch Phys Med Rehabil       Date:  2020-08-27       Impact factor: 4.060

6.  A comprehensive psychometric evaluation of the UK FIM + FAM.

Authors:  Lynne Turner-Stokes; Richard J Siegert
Journal:  Disabil Rehabil       Date:  2013-02-05       Impact factor: 3.033

7.  Retrospective Analysis of Functional and Tracheostomy (Decannulation) Outcomes in Patients with Brain Injury in a Hyperacute Rehabilitation Unit.

Authors:  Lin Cheng; Kay Mitton; Krystyna Walton; Manoj Sivan
Journal:  J Rehabil Med Clin Commun       Date:  2019-12-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.